HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...

The LGBTQIA+ community and supporters participated in this year’s Honolulu AIDS Walk on Saturday to raise awareness about the ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or every-other-month injections.

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...

Prevention Point Philadelphia, a nonprofit, has been on the front lines of harm reduction for more than 30 years.

Over the course of May 12th to 26th, the Gay Health Network (GHN) gracefully welcomed its thirtieth year in action in the ...